Matthew Herper on Muck Rack

Matthew Herper Verified

New York
Senior Editor — Forbes
Is this you? Contact us to claim or edit this page

Forbes reporter covering science and medicine

Why Americans Still Shouldn't Be Scared Of Catching Ebola

forbes.com — The utter failure of state and federal authorizes to protect two nurses who treated a Liberian Ebola patient in Texas make it seem that America's defenses against this deadly virus have crumbled. That the Centers for Disease Control & Prevention may have told one of those nurses she could get [...]

Ebola Outbreak Shows The Dark Side Of Mother Nature

forbes.com — It was an amber August night in Western Uganda in 2007. As the director of the U.S. Centers for Disease Control and Prevention (CDC), I suited up in full biosafety gear to observe a team of our top disease detectives as they tried to find the source of a deadly [...]

The Serious Problem With Obama's Ebola Czar Choice

forbes.com — Both CNBC and CNN are reporting that the White House has named Ron Klain, a former chief of staff for Vice Presidents Gore and Biden, as the point man who will coordinate the administration's response to the threat of Ebola patients showing up in the U.S. At first blush, Klain [...]

Biotech's Builder: How The Pharma's Landlord Could Benefit From The Drug Boom

forbes.com — In Manhattan, overlooking the East River and sandwiched between New York University Langone Medical Center and Bellevue Hospital, two gleaming 16-story towers act as beacons to the booming biotech sector. Completed in 2010, the 310,000-square-foot Alexandria Center for Life Science is already 100% occupied.

The World's Most Expensive Drugs

forbes.com — When people talk about expensive drugs, they usually are referring to drugs like Lipitor for high cholesterol ($1,500 a year), Zyprexa for schizophrenia ($7,000 a year) or Avastin for cancer ($50,000 a year). But none of these medicines come close to making Forbes' exclusive survey of the most expensive medicines on the planet.

A Drug Regrew A Little Girl's Missing Bones. How Much Should That Cost?

forbes.com — Evie Elsaesser is five years old and she loves to run. And that is a medical miracle. When Evie was born, much of her skeleton remained soft and un-calcified. Her arms were short, her ribs tiny, and her legs bowed. They curled up under her as if she was doing yoga.

60 Minutes Just Attacked High Drug Prices. Here's What You Should Know

forbes.com — 60 Minutes, the most successful news program in American history, just took aim at the extraordinarily high ($100,000 per patient per year) prices charged for cancer drugs. The pharmaceutical industry, which only provided canned statements and badly thought-out explanation via the president of its lobbying group, came off looking callous [...]

Zafgen Aims Obesity Drug At Deadly Rare Disease

forbes.com — The first time I wrote about Zafgen and its chief executive, Tom Hughes, I saw him as one of a large group of ex-Big-Pharma executives who were now running tiny, lean companies to test big ideas and change the way drugs are designed. At the time, Zafgen was aiming for [...]

Celgene And Sanofi CEOs To Join Third Forbes Healthcare Summit

forbes.com — On December 3 and December 4, Forbes will be hosting the third annual Forbes Healthcare Summit here in Manhattan. This invite-only event has become a big success for us -- a convergence point for big thinkers from pharmaceuticals, insurance, hospitals, and science -- and I'm really excited that this year [...]

For Second Act, Acorda Drops $525 Million On Inhaled Parkinson's Drug

forbes.com — A big all-cash deal just entered stage left for Acorda Therapeutics. Chief Executive Ron Cohen, 58, an internist and former off-Broadway actor, has built Acorda, which he founded in 1995, into a profitable concern with $355 million in sales over the past four quarters, almost all of it from Ampyra, a [...]
More Articles →
Oct 20, 2014

RT @dgmacarthur: TL with a surprise twist: IGF2, well-established as maternally imprinted, flips to paternally imprinted in the brain. #ASHG14

Oct 20, 2014

RT @carlzimmer: He then replied with insulting condescension. Then, when things got rough, he deleted @alexnazaryan. So we’re left with a phantom dialogue.

Oct 20, 2014

RT @edyong209: This thread, starting four responses down, is a masterclass in how NOT to respond to criticism. twitter.com/ejwillingham/s… HT @ejwillingham

Oct 20, 2014

The Great #Ebola Panic, might make Americans wake up about the danger of infectious disease, says @kurteichenwald newsweek.com/fear-infectiou…

Oct 20, 2014

@Mad_Scientist2 It meant it was the first social network about projecting who you are to everyone. I don't think it's so, but interesting.

Oct 20, 2014

@adamfeuerstein And I'd kind of expected to sneak out after Peter Thiel.

Oct 20, 2014

Forbes Under 30 Summit: How Biology Reinvents The Way We Understand Disease onforb.es/1DtybTx via @forbes

Learn how to connect with Matthew on social media by joining Muck Rack Pro



Are You a Journalist?

Make a Portfolio

Create a free Muck Rack account to customize your profile and upload a portfolio of your best work.


Share This Profile